Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-28 @ 12:09 PM
Study NCT ID:
NCT01599559
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-10-24
First Post:
2012-05-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma
Sponsor:
International Extranodal Lymphoma Study Group (IELSG)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2029-12-17
Completion Date Type:
ESTIMATED
First Submit Date:
2012-05-10
First Submit QC Date:
None
Study First Post Date:
2012-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-10-24
Last Update Post Date Type:
ACTUAL